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INTRODUCTION
“The evidence is clear: Family planning improves health, reduces poverty, and empowers women”
(Bongaarts et al. 2012). Voluntary high-quality family planning programs speed fertility declines, thus
improving health and boosting economies. Indeed, they are among the most cost-effective health and
development investments available to governments (Bongaarts et al. 2012; Cleland et al. 2006). The case
for family planning has been made, yet more than 200 million women in the developing world who want
to avoid pregnancy are not using a modern contraceptive method. The reasons for this are many,
including lack of access to information and appropriate health services, traditional gender norms that
impede women’s ability to adopt contraception, community and gatekeepers’ (husband, in-laws, partners)
opposition, real and perceived concerns about safety and side effects, and cost, among others.
Underlying socio-behavioral issues, including risk perception, ambivalence, and social costs, may also
play a role in demand and use.

An Opportune Moment
After a decade of waning investment in family planning (FP), we are now witnessing a resurgence of
interest and funding. This is an opportune moment to address the unfinished family planning agenda
(Cleland et al. 2006). The International Family Planning Summit held in London in July 2012 witnessed
unprecedented levels of financial and political commitment from national governments and the
international community to achieve the goal of 120 million new users of contraceptives by 2020. This
goal is to be achieved through a coordinated effort, known as FP2020, through implementing four broad
objectives:
Increase political commitment and accountability for delivery of family planning services
Contribute to substantially increased access to family planning information, services, and
supplies
Create a healthy and sustainable market for family planning commodities
Adapt and develop new and innovative contraceptive methods
This paper is intended to help guide discussions and considerations regarding the key evidence gaps and
research investments needed to achieve the FP2020 goal and objectives. The paper focuses primarily on
the social science, implementation, and operations research that will be needed to achieve the first three
objectives. The contraceptive research and development (R&D) needed for the fourth objective is the
subject of another initiative.

What We Know
Simply stated, we know that the most effective approach to achieving the FP2020 goal is to ensure
universal access to family planning, so that all women have access to a full range of effective, acceptable,
and affordable contraceptive methods appropriate to their needs and situation, made available through
multiple service delivery channels in a reliable fashion. Achieving this, however, requires political will,
human and economic resources, technical expertise, vision, and leadership. Context also matters. The
diversity of needs, populations, and reproductive intentions of individuals and couples, along with the
maturity of programming and the strength of particular national health systems, will influence the
effectiveness and impact of investments in FP2020.
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Research on family planning has made great strides in generating evidence about how it improves lives
through reducing adverse health outcomes associated with unintended pregnancy, reducing poverty by
facilitating economic development and improving women’s and girls’ social status. As the availability and
use of FP information and services have increased over the past three decades, however, so has the need
for evidence-based policy guidance, as well as evidence-based strategies for programming and financing.
Moreover, the degree to which strategies and best practices proven through small-scale projects can be
and have been scaled up within national health systems is not well understood.
The design and implementation of FP services over this period has benefited from donor investments in
social science, implementation, and operations research that has generated a substantial body of
evidence, some of which is context-specific but much of which can be generalized across social milieu
and health systems (Jacobstein et al. 2013). This paper reviews the evidence base to identify what is
currently known about FP services and what evidence gaps still exist for which further investments in
research will be critical for informing the design, implementation and evaluation of FP2020 initiatives.

METHODOLOGY
Given the scale and diversity of the evidence base, we initially identified a number of rigorous literature
reviews that have been conducted on the topic and published within the past five years. Where
appropriate, other key documents with relevant evidence were gleaned from reviews and informed
experts (Jacobstein et al. 2013). In addition, the recent World Health Organization (WHO) prioritization
exercises (Ali et al. 2012; Hindin et al. 2013)and USAID’s ‘High Impact Practices’ (HIP) documents
(K4Health 2012) were reviewed. Several systematic reviews, some following the Cochrane review
methodology, were also identified. From these reviews, and drawing from expert informants and our
own experience, we identified documentary sources that were considered to present research-based
evidence of sufficient quality and rigor to be included. We included reviews that reported evidence
generated through a range of research methods (demographic, social science, epidemiologic, policy
analysis, and implementation science/operations research) and excluded evidence from biomedical,
clinical trials, and other product development research. The evidence was collected and collated
according to a theory of change framework.

Theory of Change Framework
Numerous frameworks exist for conceptualizing the determinants and consequences of contraceptive
use dynamics. We approached this review and analysis through the lens of a theory of change comprising
five critical and interrelated elements:
Social determinants of FP demand and use
Health system determinants
Demand and use dynamics
Associations between FP use, non-use, and distal outcomes
Research, monitoring, and evaluation
Based on this theory of change, and in consultation with the expert informants, we prepared a detailed
list of topics and assigned them to the appropriate elements in a Review Framework that guides the
presentation of the summary of evidence below.
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Evidence from the Review
Social Determinants of FP Demand and Use
Many social determinants can influence demand for and use of FP, either individually or in various
combinations. In developing countries, the most influential determinants are typically: girls’ and women’s
social status and decision-making power; level of education; marital status; economic status; age; place of
residence; and experience of violence (Bongaarts et al. 2012; Cleland et al. 2006; Creanga et al. 2011;
Gillespie et al. 2007; Malarcher et al. 2011; DFID 2010b; DFID 2010a; Ortayli and Malarcher 2010). In
some settings, ethnicity, migrant status, and HIV status can also be key determining factors. The role of
these social determinants in shaping demand for and use of FP is well documented (Cleland et al. 2006;
DFID 2010b), and evidence from multiple settings and populations exists that can be used to advocate
for the importance of understanding which factors are the most influential in determining demand and
use in a particular setting, and, in turn, for identifying those populations that are the most underserved
and have the highest unmet need.
Framing this evidence from an equity perspective is critically important so as to focus policy and
programmatic attention on identifying the most disadvantaged, vulnerable, and underserved
populations with unmet need (Creanga et al. 2011; Gillespie et al. 2007). Reducing inequities in access
and use are central to implementing a rights-based approach to providing FP services and inherent in
the goal of MDG 5B: achieving universal access to reproductive health (RH), including family
planning. Inequity reduction is also central to FP2020’s focus on rights and empowerment.
The extent to which social determinants interact and influence demand for, access to, and use of FP
services, and consequently contribute to inequities, is highly context-and population-dependent. Situationspecific analyses should thus be undertaken to generate evidence for guiding rights-based policy/program
development in all countries (Ortayli and Malarcher 2010). For example, most, but not all, Demographic
and Health Surveys (DHS) include standard indicators for many of the social determinants and thus
3

provide an easily accessible data source (Malarcher et al. 2011; Ortayli and Malarcher 2010). Most of the
evidence on social determinants comes, however, from cross-sectional surveys, such as the DHS, whereas
longitudinal data could better demonstrate causality. Numerous demographic surveillance systems (DSS),
which collect longitudinal data on a range of health indicators, exist in developing countries, but
unfortunately very few routinely collect data on contraceptive use and fertility.
Although the DHS can provide much useful data for an overall understanding of many social
determinants of unmet need and unintended pregnancy, it generally lacks sufficient data to enable a full
understanding of unmet need among key populations suffering from social inequities, notably married
and unmarred adolescents, marginalized ethnic populations, urban slum dwellers, and people living with
HIV/AIDS (PLWHA). Because the adverse health, social, and economic outcomes of unintended
pregnancies among these populations are generally more serious than among other populations
(Gipson, Koenig and Hindin 2008; Malarcher et al. 2011), in-depth analyses of vulnerable populations
are essential to generate evidence for rights-based policy and program development.
Although the evidence of population-level associations is fairly strong and convincing (DFID 2010b),
evaluated interventions that explicitly seek to address the underlying determinants that lead to inequities
in access to and use of FP are relatively scarce (DFID 2010b; DFID 2010a). This is primarily because
such “structural” interventions are usually implemented with the goal of broader social change and
require large-scale complex interventions that may or may not explicitly include changes in reproductive
intentions and contraceptive use. However, structural interventions are emerging that are intended to
have a direct impact on access to and use of FP among populations suffering from specific inequities.
Examples include reaching unmarried adolescents with appropriate information and services, reducing
early marriage and reaching married adolescents with supportive information and services, reducing
poverty-induced barriers, and reaching PLWHA. Evidence gaps persist in how to tackle these
determinants, as well as for interventions that address: i) violence reduction and contraceptive use,
especially for adolescent girls; ii) unintended pregnancy among populations living in urban slums,
especially adolescents; and iii) girls and women engaged in sex work.
Adolescents are a diverse group of 10-19 year olds whose capacities and needs differ by age, sex, living
arrangements, area of residence, level of education, and by their marital, childbearing, and employment
status. Given this heterogeneity, addressing adolescent RH needs presents complex challenges.
Although some trends in adolescent health and social outcomes have improved over the past three
decades—including school enrollment and retention, early marriage, and early pregnancy (WHO
2011)—disparities in many adolescent health outcomes persist by age, income, gender, region, and
other socio-cultural factors.
Interventions seeking to reduce sexual risk-taking among adolescents have become increasingly common
in developing countries in the past decade. These interventions have taken a variety of configurations,
from conventional sex education in schools to multi-component, cross-sector efforts aimed at improving
educational and economic opportunities and delaying marriage. Relatively few of these have been
rigorously evaluated; and the majority of programs that have been evaluated are small in scale and
implemented over a relatively brief period. There is a paucity of information concerning intervention
costs, and little evidence regarding long-term behavioral effects (Speizer, Magnani and Colvin 2003).
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Key determinants of adolescent pregnancy include early marriage, sexual coercion, and lack of access to
and use of appropriate contraceptives. A recent systematic review (Lee-Rife et al. 2012) found little
evidence concerning the effect of various non-health interventions on unintended pregnancy, and the
evidence that does exist is generally weak. As a result, WHO made several research recommendations: i)
assess the impact of improved educational availability on age of marriage; ii) assess the feasibility and
long-term impact of economic incentives to girls and their families as a means of delaying age of
marriage; iii) determine the effect of formal and non-formal education on adolescent pregnancy
prevention; and iv) determine the effect of school-retention interventions (e.g., conditional or
unconditional cash-transfer interventions) on delaying pregnancy. For addressing coerced sex, WHO
recommends engaging men and boys to alter gender norms and normative behaviors, and highlights the
need for research to assess how laws and policies to prevent coerced sex have been formulated,
enforced, and monitored and to determine the effectiveness of these laws and policies in preventing
coerced sex among adolescents.
Awareness of FP and Contraceptive Technologies
Raising awareness of the benefits of preventing unintended pregnancies and thereby enabling
individuals and couples to plan “children by choice not chance” through using contraceptive
technologies has a long history (Bongaarts et al. 2012; DFID 2010a). A substantial evidence base exists
regarding the use of information, education, and communication (IEC) and social and behavior change
communications (SBCC) strategies to generate demand for FP generally, and (to a lesser extent) for
specific groups of contraceptive technologies (e.g., long-acting reversible methods, male methods, etc.).
Four broad categories of demand generation interventions can be considered. Evidence from quasiexperimental designs indicates that mass media campaigns can generate an immediate demand for FP
services and are associated with approval of FP and greater partner communication about FP and
increased contraceptive use. “Edutainment” programs through radio and TV dramas are associated with
increased contact with FP providers, greater use of FP, and decreased desired family size (Bongaarts et
al. 2012; Mwaikambo et al. 2011; Westoff, Koffman and Moreau 2011). Community mobilization
approaches are usually implemented jointly with service delivery through community health worker
(CHW) programs or social marketing programs, both of which have been found to have substantial
effects on the demand for and use of FP (DFID 2010a). Evidence also supports the effectiveness of
interventions that increase interpersonal communications, especially between young people,
partners/couples, other family members, or social peers (DFID 2010a; Mwaikambo et al. 2011). Recent
developments in mhealth for generating FP demand have stimulated much interest, and several pilot
projects are currently underway, but little evidence exists because results have not yet been published
(L’Engle 2012).
Because vulnerable populations are generally more isolated, poorer and less literate, they are also less
likely to be exposed to many of these demand generation interventions (Ortayli and Malarcher 2010).
Moreover, the relevance, or perceived relevance, of these messages may be particularly low for
vulnerable populations, for example married girls and female sex workers. The extent to which
vulnerable populations are reached by these types of interventions and the extent to which the
interventions have an effect on such populations remain under-researched and should be highlighted
in future evaluations of demand generation interventions. Social marketing organizations are often
required to report on the extent to which their campaigns reach the poorest and most vulnerable
populations, and such analyses should be integral to the design and evaluation of future demand
generation interventions.
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Reducing unmet need is the primary goal of FP2020. Focusing on reducing unmet need implicitly
assumes that a demand for FP already exists and is being partially met. However, although awareness
of the benefits of FP are widely known in most regions of the world (apart from West Africa),
knowledge of contraceptive technologies and how to obtain them is often incomplete and inaccurate.
Thus, unfounded concerns regarding side effects are widespread, contributing to personal and partner
opposition to contraception (Darroch, Sedgh and Ball 2011). Strategic communication strategies
(Bongaarts et al. 2012) are therefore still needed within the FP2020 framework, especially for
populations without full awareness of the range of contraceptive alternatives available, how they
function, and how to access them. The evidence base regarding interventions tailored to address
method-related concerns is thin, however.

Health System Determinants
National health systems largely (but not solely) determine the institutional structures and processes
through which FP is delivered and accessed. When considering a national health system, it is important
to consider these systems from the perspective of the “total market” (TM) through which FP is made
available, which includes public, commercial, not-for-profit, and faith-based sectors (Barnes et al. 2012).
To organize the evidence available concerning FP delivery through a total market health system, we
adopt the framework of WHO’s six “building blocks” of health systems: service delivery, human
resources, systems information, medicines, financing, and leadership and governance.
Service Delivery
Globally, the number and type of service delivery channels through which FP is delivered has increased
dramatically over the past two decades, reflecting both expansion within the public sector and the
growth of other sectors as sources of FP. To simplify the presentation of evidence, we cluster these
into seven broad channels: clinic-based; integrated with other services; community-based; mobile
outreach; social marketing and pharmacies; adolescent-friendly services; and other vulnerable
populations.
Clinic-based. Clinic-based delivery of FP services is still the main delivery channel for married women;
increasingly, this may be through non-public sector facilities as the private sector grows in many
countries. How to provide clinic-based FP services is broadly understood. The evidence challenges
primarily concern improving quality and choice. The key components of high-quality services are wellestablished, as described in the Bruce–Jain framework (Bruce 1990; Jain 2001), and substantial evidence
exists that strengthening these components does impact client-provider interactions, client satisfaction,
and effective and sustained method use (RamaRao and Mohanam 2003). Numerous quality improvement
interventions have been developed, but relatively few have been rigorously evaluated (Mwaikambo et al.
2011; RamaRao and Mohanam 2003). A recent synthesis of the evidence (Jain 2012) yielded two broad
conclusions: (a) increasing the number of methods made available to clients increases choice, which leads
to more new users, reduced discontinuation through switching, and increased prevalence overall; and (b)
improving providers’ skills and attitudes enhances their technical competence and ability to identify and
meet clients’ individual needs. The evidence base for which interventions can most efficiently increase
the number of methods offered, and which can most effectively improve providers’ skills, particularly in
counseling new clients to determine and meet their individual needs, including continued use of
hormonal methods, remains limited, however (Cleland et al. 2006; Halpern et al. 2011; RamaRao and
Mohanam 2003).
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Evidence is also limited regarding the feasibility and effectiveness of quality assurance and monitoring
mechanisms. Several have been piloted over the past two decades, but with little systematic
documentation or evaluation. Key issues concerning standardized indicators, data-collection systems,
and feedback and data utilization mechanisms remain under-researched. Quality monitoring and
assurance feature prominently in FP2020, particularly within the Monitoring and Accountability
Working Group. It is hoped that this will encourage investment in generating evidence regarding how
such mechanisms can be standardized and can function effectively and efficiently.
Increasing engagement of the commercial sector in providing FP through private clinics is particularly
noticeable through the burgeoning of social franchising. Recent reviews (Madhavan and Bishai 2010;
Mwaikambo et al. 2011; Stephenson et al. 2004) find strong evidence that franchising does increase
access to and use of FP services, moderate evidence of improved quality, and moderate evidence of
increased use by the poor. The extent to which franchising addresses equity is, however, uncertain. Only
one study has addressed cost-effectiveness, but it was inconclusive. Given the potential of this approach,
further research is justified regarding its effect on quality of care and equity as well as its relative costeffectiveness.
Integrating FP with other services. Increasing emphasis is being placed on integrating FP into other health
services, acknowledging both that women’s RH needs are often multiple and that a visit to a clinic
represents a valuable and perhaps rare opportunity to address a woman’s FP needs. The evidence base
concerning the feasibility, acceptability, effectiveness, and cost-effectiveness of integrating FP into
various maternal, infant, and child health services is extensive, yet awareness of this evidence and its
routine use in programming, especially for postpartum FP services, remains remarkably limited. Recent
reviews usefully summarize the evidence (Hiller, Griffith and Jenner 2007; MCHIP 2012; Vernon 2009)
and provide programmatic recommendations for which models of integration with maternal, newborn,
and child health services have been demonstrated to be effective and thus should be scaled-up. There
appear to be few major evidence gaps. Some issues that would benefit from further evidence are: how
best to link FP counseling during antenatal care (ANC) with postpartum use; how to involve male
partners; whether tubal ligations can be offered safely and with informed choice following caesarean
sections; whether child immunization visits are a cost-effective opportunity; and method preferences
among postpartum women living with HIV (MCHIP 2012). Women at 12 months postpartum have
extremely high levels of unmet need (near 65%); thus, investing in scaling up evidence-based postpartum
FP strategies should be a priority for FP2020.
For almost two decades, postabortion care (PAC) has explicitly incorporated counseling and, if desired,
delivery of FP. When FP is routinely offered to PAC clients, the evidence is unequivocal that clients are
more likely to receive a contraceptive method than when it is not (USAID 2012c) and so is considered
a proven best practice. The one study to evaluate longer-term outcomes found that exposure to
postabortion FP resulted in significantly fewer abortions and unintended pregnancies during the 12month follow-up period (Johnson et al. 2002; USAID 2012c). No study exists, however, on the impact
on maternal mortality and morbidity of providing postabortion FP (Tripney et al. 2011; Tripney, Kwan
and Bird In press).
In most developing countries, post-rape care is still a nascent RH service, although growing
recognition of the scale and severity of sexual assault means greater investment in piloting countryspecific models and preparing for scale-up. Emergency contraception (EC) is an integral component of
any post-rape care model, as 5-18% of rapes result in a pregnancy. Evidence currently available is
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limited to documenting the feasibility of offering EC within a comprehensive package of services
(Keesbury and Thompson 2010). No evidence exists of its effectiveness in reducing pregnancy
following rape.
The rationale for integrating FP with HIV services is well-established, both through offering FP within
HIV services and HIV services within FP services (Wilcher, Cates and Gregson 2009). Moreover,
evidence concerning the feasibility of various models of integration is sufficiently strong to support
investment in piloting and scaling up (Church and Mayhew 2009; Spaulding, Brickley and Kennedy
2009). The evidence base describing which models work more effectively, efficiently, and equitably is still
modest, and is characterized by generally low levels of scientific rigor. However, recent significant
investments in rigorous evaluations of integrated models that measure their association with unintended
pregnancies, HIV/STI incidence and stigma, as well as comparisons of outcomes between linked
services with stand-alone services, will yield substantial improvements in the quantity and quality of the
evidence base over the next couple of years.
Moreover, from an HIV-prevention perspective, evidence from modeling demonstrates that reducing
unmet need for FP, and consequently unintended pregnancies, in a population with high HIV
prevalence (with or without women knowing their status) has a significant impact on reducing perinatal
HIV transmission (Reynolds et al. 2008). A recent review of the evidence by a WHO expert group
found conflicting evidence regarding whether women using progestin-only injectable contraceptives
may be at increased risk of HIV acquisition. The review recommended that women using progestinonly injectable contraceptives be strongly advised to also use condoms and other preventive measures
(WHO 2012a).
Community-based. Community-based distribution (CBD) of FP has been an important strategy in all
regions of the world for more than three decades. A vast body of documented experience, together with
research-based evidence from numerous evaluations with varying levels of rigor, has demonstrated the
acceptability, effectiveness (in generating demand and increasing access and use), and cost-effectiveness
of CBD agents, as well as providing programmatic guidance for implementation (Mwaikambo et al. 2011;
Phillips, Greene and Jackson 1999).
With the realization that providing FP through multipurpose CHWs is more efficient and better meets
women’s needs than through CBD agents, attention has shifted to identifying the evidence concerning
CHWs as a source of FP information and services. A recent review (USAID 2012a) using evidence with
varying levels of rigor showed that: (a) CHWs can meet the immediate and growing need for human
resources where services are most needed; (b) CHWs can help reduce inequities in FP use and
particularly for women with constrained mobility; and (c) CHWs can safely and effectively provide a
wide range of methods, including pills, condoms, injectables, Standard Days Method (SDM), lactational
amenorrhea method (LAM), and EC. Preliminary evidence also indicates that under appropriate
conditions, CHWs can provide implants and intrauterine devices (IUDs). Further evidence is needed
concerning the safety and impact of CHWs providing these long-acting methods. Evidence gaps also
remain concerning the role of CHWs in meeting the needs of unmarried adolescents, recently married
girls, males, and urban slum populations; the relative cost-effectiveness of CHWs compared with clinicbased and mobile outreach models; and the feasibility and effectiveness of outreach workers in other
sectors (e.g., agriculture, development) as FP providers.
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Mobile outreach. Provision of long-acting contraceptive methods by a mobile team of trained providers, in
a modified vehicle or in a temporary facility or camp, has been a strategy used for many years but with
little research-based evidence to describe performance or effectiveness. A recent review of the existing
evidence (USAID 2012b) indicates that, in many settings, mobile outreach can: (a) supply between onefifth and more than one-half of all users of particular methods; (b) outperform fixed facilities and at a
lower cost; (c) reduce some inequities by reaching some underserved populations, especially those living
in remote locations; and (d) reach women who have never previously used any FP. The evidence base
remains limited, however, regarding issues such as women’s health-seeking behaviors for complications,
switching or discontinuation, client satisfaction, overall quality of service, reaching vulnerable
populations living in remote locations, and the cost-effectiveness of mobile outreach.
Social marketing and pharmacies. Using commercial-marketing techniques to promote socially beneficial
behaviors and make available subsidized FP commodities and services through commercial outlets is an
increasingly popular service delivery model, particularly for delivering short-acting methods such as pills
(including EC), condoms, SDM (cycle beads) and injectables. A recent review (Madhavan and Bishai
2010) found moderate evidence that social marketing increases access to FP products and messages,
though their effect on inequities was not measured. Strong evidence was found of the cost effectiveness
of social marketing, and moderate evidence that increasing price reduces use. One review (Chapman and
Astatke 2003) found that the socioeconomic status of women served through social marketing tends to
be lower than women purchasing commercial brands and higher than those who obtain their products
from the public sector.
Although pharmacies often participate in social marketing programs, little evidence exists regarding the
role that pharmacies and drug shops can play when specific interventions are introduced to strengthen
their capacity to offer FP services. A recent review (Solo and Malarcher 2012) summarizes the limited
evidence of their ability to safely provide many methods, and their potential to reach urban poor
populations, including unmarried adolescents and males who may be stigmatized when visiting clinics.
It also notes that rigorous evidence is lacking on these issues as well as on quality of care and the costeffectiveness of the approach.
Married and unmarried adolescents. Many interventions have been developed to reduce health systems
barriers for adolescents, but few have been rigorously evaluated. A recent systematic review (WHO 2011,
2012c) found little evidence, and the evidence that does exist is generally fairly weak. As a result, several
research recommendations were made: (a) identify feasible and effective interventions that result in the
formulation of laws and policies that reduce barriers to adolescents accessing contraceptives; (b) identify
and evaluate interventions that influence community members’ support for access to contraceptives
among adolescents; (c) identify feasible and effective interventions to improve the availability of overthe-counter hormonal contraceptives to adolescents; (d) determine the effectiveness of interventions that
provide accurate information and education about contraceptives in various settings and populations
(both in-school and out-of-school); (e) identify feasible and effective interventions that involve
adolescent and adult males in decisions concerning contraceptive use by partners and by themselves,
including interventions that aim to transform gender norms; (f) determine the feasibility, sustainability,
and impact of reducing the cost of contraceptives for adolescents.
The majority of sexually active adolescent girls in developing countries are married (Haberland 2003), yet
health system-based interventions to address the FP needs of married adolescents are relatively new, and
generally seek to reach and support married adolescent girls and their husbands and families with
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targeted activities and services. Few rigorous evaluations have been undertaken but a number of
promising practices are emerging from studies using quasi-experimental designs. Such studies feature
combined community, couple, and individual SBCC strategies to build a supportive social environment,
and education-and home-based supply of FP, especially during the postpartum period following the first
birth (DFID 2010a).
Other vulnerable populations. The evidence base regarding the particularities of delivering FP services to
urban slum dwellers, and especially to young people, is growing with recent substantial investments in
urban-focused FP programs and an independent, complementary evaluation project. More evidence will
be needed as the number and range of urban-focused interventions expands rapidly through FP2020; in
particular, evidence of such interventions to reduce inequities within urban populations, especially young
and unmarried populations. The private sector is likely to feature prominently as a source of
commodities, and the electronic media, especially mobile phones, as a source of information. As urban
slum populations continue to grow exponentially and with young populations, the importance of
generating a rigorous evidence base to guide programming for meeting the needs of the urban youth
living in poverty cannot be exaggerated.
As noted above, the evidence base for interventions that meet the FP needs of women living with HIV
is growing rapidly through both research and experience. With an initial focus on integrating FP
services into prevention of mother-to-child transmission (PMTCT) and ART services for HIV-positive
women in high prevalence settings, there are increasing efforts to determine the client’s HIV status
during FP, ANC, and postpartum services so that the consultation can be tailored to meet their needs
during a routine consultation rather than through stand-alone HIV services. Evidence for how this
expanded service can best be done is still emerging.
Unintended pregnancy and use of contraceptives among sex workers is poorly understood. No
systematic review of this sparse literature has been conducted. Such a review would be helpful because
the evidence available is unclear regarding whether sex workers have higher or lower levels of unmet
need than the general population. Nomadic and migratory populations, although relatively small in
number, are highly vulnerable and their needs can be acute. No evidence exists concerning service
delivery or models for reaching them, however.
Human Resources
Many cadres of health workers have been trained to provide FP information, counseling, and services.
Task shifting and sharing are currently being promoted as a strategy for expanding access to FP through
enabling larger numbers of health workers to offer a wider range of methods. A recent review of the task
sharing evidence (WHO 2012b) produced recommendations for which cadre could safely and effectively
provide which types of contraceptive method. This review also identified some evidence gaps that need
to be addressed through rigorous research so that a determination can be made concerning whether the
following cadres can provide the following contraceptives: (a) trained Lay Health Workers and
Traditional Birth Attendants (TBAs) providing implants; (b) auxiliary nurses providing IUDs and
vasectomy; (c) auxiliary nurse midwives providing vasectomy; and (d) nurses and midwives providing
tubal ligation and vasectomy. It also recommends two situations in which cadres should provide
methods although with targeted monitoring and evaluation (M&E): i) Lay Health Workers and TBAs
providing injectables; and ii) auxiliary nurses and auxiliary nurse midwives providing implants.
Additionally, the review recommended that, for services for which the evidence does support task
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shifting or sharing without further research—namely, auxiliary nurses and auxiliary nurse-midwives
providing injectables, and nurses and nurse-midwives providing implants—national programs should be
provided with technical assistance to rapidly amend policies and programs to scale up the evidence-based
best practices.
As health systems expand their capacity to offer FP services, a focus on task sharing should not divert
attention from broader human resource concerns that can prevent health systems from functioning at
full potential (DFID 2010b). Staff shortages, their distribution and rotation, skills competency, lack of
supervision, and other human resource issues, are frequently cited as barriers during implementation of
new FP interventions. Localized evidence is needed to identify solutions to these problems that can be
generated primarily through health systems research methods such as training audits, competency
assessments, case studies, health facility assessments, and policy analysis.
A second area in which evidence is needed urgently is the role of electronic and mobile information and
communication technology for training, monitoring, and supervising health workers. Despite the great
interest in and potential for these technologies to improve provider competence and system efficiency,
no rigorous evidence of feasibility, acceptability, effectiveness, and cost-effectiveness exists. Great care is
needed, therefore, to ensure that large-scale ehealth/mhealth interventions are not rolled out without
sufficient evidence to determine how their introduction will impact the health system.
Systems Information
Effective and efficient delivery of FP services requires the production, analysis, and communication of
data regarding the performance of service delivery sites and providers, and the relation between use of
FP services and achievement of reproductive intentions through prevention of unintended pregnancy.
Performance monitoring will be critical if the FP2020 goals are to be achieved. The collection,
processing and use of performance-related data is usually organized through the design and
implementation of an M&E strategy. M&E strategies are informed primarily through experiential rather
than research-based evidence and usually conceptualized according to logical frameworks based on a
“theory of change.” At the heart of most M&E strategies for FP service delivery is a health management
information system (HMIS) that records and reports the delivery of FP services.
Most national HMISs are notoriously weak at monitoring FP performance. Incorporating data from the
non-public sector into an HMIS has proved difficult. Because HMISs also do not usually track client
characteristics, monitoring whether inequities are being reduced will be difficult without changes.
Because they also do not regularly monitor quality of care, sufficient investments will be needed to
strengthen and amend national HMISs and link them with the evolving global framework being
developed by the FP2020 Performance Monitoring and Accountability Working Group. Moreover, if
an accountability mechanism is to be established and function so that it can routinely track that service
delivery is rights-based, it will need to be linked directly with the national HMIS.
Although the overall goal of FP2020, 120 million new users, can be tracked through a strengthened
HMIS, the population-level impacts of the various interventions implemented to meet this goal will also
need to be measured through data generated through representatively sampled surveys. Historically, the
DHS mechanism has provided these data, but with the increased focus on unmet need, unintended
pregnancy, and equitable access—all measures that require population-level samples—there is likely to
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be a need for increased investment in surveys, including in the human resources to undertake them,
analyze the findings, and support the uptake of this evidence by stakeholders and decision-makers.
Paper-based HMISs are increasingly being replaced by electronic systems, handheld devices for data
collection and transmission, and computerized analyses are informing budgeting and planning
decisions. Despite their rapid increase, rigorously tested and validated electronic HMISs that can be
used with ease by program and clinic managers are still a minority. Substantial investment in
computerization of national HMISs and in building human resource capacity to use them effectively
should be a priority as FP2020 rolls out at the country level.
Commodities
Maximizing global access to FP commodities in accordance with quality assurance requirements at
affordable and sustainable prices, or “market shaping,” is one of the objectives of FP2020. Problems
with FP commodity production, pricing, forecasting procurement needs, efficient supply logistics, and
quality assurance have all been identified as key barriers that restrict access and choice for women
wishing to use FP, thereby contributing to unmet need. To plan for and implement a market-shaping
strategy that will reduce these barriers to develop a more efficient, effective, and equitable market for
FP commodities will require substantially more evidence than is currently available. For example, the
FP2020 Market Dynamics Working Group is expected to improve processes and tools for demand
forecasting, coordinated procurement, harnessing innovative financing, strengthening supply chains,
and testing innovative products. All of these processes and tools will require valid, regular data, some of
which can be generated through an HMIS, but most will need to be documented and analyzed through
new procedures and mechanisms.
In particular, validated TM approaches will be needed to assess the characteristics of existing and likely
future markets, and to define the comparative advantage of commercial, social marketing, nongovernmental organization (NGO), and public sector actors in terms of their competence and value for
money in delivering a range of products or services to different market segments, including the poorest.
Rigorous methods for defining, measuring, and monitoring method mix, both in terms of demand and
supply, will be essential for maximizing choice. Evidence to support the bridging from product
development to market introduction is lacking. Conceptual frameworks and critical pathways exist, but
with limited validation and demonstration of utility across the spectrum of methods.
Some specific evidence gaps exist for the provision of individual contraceptive commodities:
Condoms: Male condom use is increasing rapidly among unmarried people, especially in Africa.
Evidence is needed regarding how to sustain its use after marriage, especially as a dual protection
strategy. Evidence concerning programming for female condoms (FC) is increasing slowly; until
recently there has been limited interest in FC as a family planning method per se among potential
users and providers. Provider and policy bias has inhibited investment in research and programming,
although that has begun to change with the recent development of newer models of female condoms
coming on the market.
Contraceptive vaginal rings (CVR): Extensive research is needed regarding how best to introduce
and mainstream both progesterone-only and other CVRs. For the latter, market forecasting for
developing countries and evidence are needed to inform strategies for affordable production,
procurement, and sales.
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Emergency Contraception (EC): Although evidence-based guidance concerning the introduction
and mainstreaming of EC products does exist (Hossain and et al. 2009), the UN Commission on
Life-Saving Commodities for Women and Children has included EC (together with implants and
FCs) in its list of over-looked commodities. Earmarked investments will become available to expand
the evidence base regarding the supply of this commodity.
Injectables: This is the most rapidly increasing contraceptive commodity being used in Africa.
The implications of this rapid increase in access and use need better understanding, especially in
countries with high HIV prevalence for which concerns remain about its possible association
with HIV acquisition. Conversely, use of injectables in South Asia is relatively limited, and more
evidence is needed to determine whether there is greater potential demand and if so, how this
could best be met.
Implants: Evidence concerning implants is fairly complete, with the main gap being the extent to
which provision of this method can be task shifted to lower-level cadres to increase access,
especially in rural areas. Evidence concerning their use by adolescents is limited.
IUD/intrauterine system: The evidence regarding reasons for non-use is generally quite good.
The main evidence gap is the extent to which method provision can be task shifted to lower-level
cadres to increase access, especially in rural areas.
LAM: Evidence is still needed regarding how best to facilitate the transition from LAM to an
effective contraceptive technology after breastfeeding.
Oral contraceptive pills: No further evidence seems to be needed at this point in time.
SDM: Evidence suggests that demand exists for SDM and that this can increase as availability
and awareness increase. The method is most popular among women not currently using an
effective method, thus providing programs a strategy to reach underserved couples; how best to
do this needs informing through locally obtained evidence (Lundgren 2012).
Tubal ligation: Options for easier procedures are currently being explored and evidence is needed
to determine the extent to which lower cadres can task share its provision.
Vasectomy: Evidence is needed concerning the reasons for non-use and to identify innovative
and effective ways to communicate messages, especially in Africa.
What is next? Emerging contraceptive and multipurpose prevention technologies (MPTs): A
diverse set of research endeavors will be needed as new technologies enter into clinical trials and
pre-introduction studies.
Financing
Increased effectiveness and efficiency in health systems functioning is intimately tied to the way in which
systems are financed. Most public sector and NGO health programs pay for the inputs needed to
produce FP services and not for their performance outputs or outcomes (i.e., whether FP services are
actually delivered or whether the population’s RH improves). Paying for performance (P4P), result-based
financing (RBF), output-based aid (OBA), performance-based financing (PBF) performance-based
incentives (PBI), and other similar terms describe interventions that finance a health system through
paying for the outcomes delivered. Over the past decade, many models have been and continue to be
developed and tested using this principle, and indeed some major donors are also configuring their
service delivery tenders so that payment is performance-based.
As described by a recent Cochrane review, the evidence base for PBF is presently too weak to draw
general conclusions. PBF is not a uniform intervention; its impact depends on the interaction of several
variables, including the design of the intervention (e.g., who receives payments, the magnitude of the
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incentives, the targets and how they are measured), the amount of additional funding, other ancillary
components such as technical support, and contextual factors including the organizational context in
which it is implemented (Witter et al. 2012). For maternal health, an “evidence summit” convened in
mid-2012 provided the focus for collating and synthesizing the evidence concerning the full range of
financing mechanisms being piloted. The evidence summarized at that meeting is currently being
prepared for distribution and should be available by early 2013.
For FP specifically, several PBF mechanisms are being tried (Eichler et al. 2010): donors incorporating
PBF in the way they structure payment to countries by conditioning aid on evidence of health results;
national governments transferring funds to sub-national levels of government based partly on attainment
of health or coverage targets; donors paying NGOs for results that include FP; rewarding health facilities
for quality counseling and availability and use of modern FP methods; reducing financial barriers to
accessing FP by selling to poor women vouchers for FP services at subsidized rates from accredited
providers; and conditional cash transfer (CCT) programs providing income support to poor families if
they meet health and education conditions that include participating in health education talks about FP
and some evidence of increased FP use (Mwaikambo et al. 2011). Given the high level of interest in PBF,
further investment in research concerning these various PBF mechanisms is critical. In particular,
concerns regarding the potential for coercion when incentives are used with FP providers need to be
carefully addressed in any research (Eichler et al. 2010). In addition, the effect of PBF programming on
equity also needs to addressed, because the evidence available appears mixed (Hotchkiss 2011;
Ravindram and Fonn 2011). Moreover, the relative cost-effectiveness of alternative PBF models is an
important policy issue for which there is no firm evidence.
Many national governments have made substantial commitments to FP2020. It is likely, therefore, that
traditional “input-based” financing for FP services through allocations from the countries’ finance
ministries is likely to continue to be the predominant model in the public sector. Evidence is needed,
therefore, regarding how existing governmental financing mechanisms function and can be improved—
for example, through country-specific and meta analyses of national health accounts and other resource
tracking methods.
The influence of price on the acceptability and use of different contraceptive methods is not clear.
Definitive evidence regarding the price elasticity of contraceptive demand is still scarce, and much
evidence tends to come from observational studies from the 1980s and 1990s. Most evidence indicates
that contraceptive pricing is actually quite inelastic (Cleland et al. 2006), although income seems to be a
factor in determining elasticity, implying that the poorest are more likely to be affected by user fees
(DFID 2010a). More up-to-date rigorously designed studies are needed concerning the impact of user
fees or out-of-pocket payments on contraceptive use and RH and potential equity impacts (DFID
2010a).
Leadership and Governance
The importance of political commitment as a determinant of demand for and use of FP cannot be
overstated. Indeed, increasing such commitment is one of FP2020’s four objectives. Trends in global and
national support for FP are associated with trends in demand for and use of FP (Cleland et al. 2006;
DFID 2010b). The stall in fertility decline in sub-Saharan Africa can be attributed in large part to
ambiguous national will and reduced global commitment to FP throughout the 1990s and early 2000s
(Bongaarts et al. 2012; Cleland et al. 2006), and recent rapid increases in FP use in several African
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countries can be attributed to increased political will (Murunga et al. 2012; USAID Africa Bureau 2012).
Evidence supports the role of political commitment for increasing awareness of and demand for FP, as
well as enhancing investments in and effective implementation of service delivery strategies to reduce
unmet need (Jacobstein et al. 2013; Lee et al. 1998). Following the political and financial commitments
made at the London FP Summit in July 2012, substantial investments will be made in advocacy efforts
over the next few years to capitalize on these commitments. However, little evidence currently exists to
guide investments in advocacy, to ensure that they are effective in increasing access, reducing unmet
need, and addressing inequities. In addition to evaluations of recent and on-going advocacy initiatives
(Murunga et al. 2012; USAID Africa Bureau 2012), prospective research is needed to evaluate the
feasibility, implementation process, and effectiveness of forthcoming advocacy projects.
To ensure that these commitments translate into investments in a rights-based approach to reducing
unmet need, FP2020 will be supporting mechanisms that hold governments, donors, and other
organizations making and implementing the commitments accountable to the intended beneficiaries.
Within the FP2020 architecture, both the Rights and Empowerment and Performance Monitoring and
Accountability Working Groups will be responsible for ensuring accountability. They will require
rigorous evidence to guide them in empowering communities, especially the most marginalized, to voice
their needs and demand their entitlements, engage in decision-making to design and implement service
delivery; and monitor potential rights abuses concerning FP provision. Accountability mechanisms do
exist for FP, but evidence of their feasibility and effectiveness is limited primarily to case studies
(Bongaarts et al. 2012; DFID 2010b; DFID 2010a). In anticipation of a rapid increase in accountability
mechanisms, operations research to develop, test, and evaluate accountability interventions should be an
urgent priority.

Demand and Use Dynamics
A thorough and context-specific understanding of the demand and use dynamics for FP is critical for
planning to expand access to and reduce unmet need for FP through FP2020. Moreover, to ensure that
all responses are rights-based and will contribute to universal access through reducing inequities, all
analyses must disaggregate population-level data by the relevant social determinants for each country.
The DHS provides substantial datasets from which many analyses of demand and use dynamics have
been, and can be, undertaken. Given the scale of investment and the need to target interventions
strategically for diverse populations, undertaking additional population-specific DHS-like surveys will
probably be necessary to determine the specifics of such dynamics, especially for particularly vulnerable
and poorly-documented populations.
In determining why many women with a demand for FP have an unmet need, understanding the
reasons for non-use is an essential starting point. Unfortunately, the evidence base for understanding
the reasons for non-use is still limited, due in part to an over-reliance on the evidence generated
through the “reasons for non-use” questions used in the DHS. While useful if carefully interpreted,
there is an urgent need for additional standardized measures that are able to describe the ambivalence
women often feel concerning contraceptive use, their perceptions of various risks associated with use
or non-use, and that can capture changes over time. Moreover, more nuanced and insightful
interpretations of the responses given and their implications for investments in programming are
needed. For example, in most developing countries, lack of access or high cost are no longer the
primary reasons for non-use – infrequent sex and fear of side effects are the most commonly cited –
(Darroch et al. 2011), possibly because most investments in FP programming over the past two decades
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have been oriented towards reducing these barriers, and with apparent success. Future investment
should be determined by the key reasons, disaggregated by population groups, within each country.
Recent evidence highlights the importance of and reasons for discontinuation, switching, and failure as
factors determining unintended pregnancy and achievement of reproductive intentions (Ali, Cleland and
Shah 2012). Indeed, one-third of unintended pregnancies occur among women who are using FP (i.e.,
have a met need). Better addressing the needs of women already using FP may be as effective a means of
reducing unintended pregnancy as focusing on new users (Jain 1989). High rates of discontinuation (on
average, around 40% at 12 months) stress the need to both ensure access to longer-acting effective
methods, as well as improve service quality, particularly counseling, so that women can make an
informed choice and are forewarned about side-effects and reassured about health concerns. Timely and
informed method-switching needs to be better recognized to avoid unintended pregnancies, abortion,
and unwanted or mistimed births. A lack of longitudinal data, especially prospectively collected, hinders
better understanding of these important use dynamics.
One weakness of the DHS is that it does not adequately sample for adolescents and other non-married
women, women living in vulnerable situations (e.g., sex workers, women living with HIV) and men.
Although varying by country, these populations can suffer a significant proportion of the unmet need.
Thus, more evidence is essential to understand contraceptive demand and use dynamics among these
populations, either through strengthening the DHS or undertaking further population-specific surveys.
For example, several countries have recently commissioned surveys of young people.
Determining whether a woman is using a method that is appropriate for her needs at a particular point in
her life cycle, and whether there may be other, more suitable methods that are not available to her, is an
important element of use dynamics that influences choice. It can also affect the likelihood of unintended
pregnancy if she is using a less effective method because more effective options are not available,
accessible, affordable, or acceptable. And it can potentially affect the cost of using and of providing
contraceptives. Longer-acting methods generally cost less per couple year of protection (cost is
amortized over longer term), than short-acting methods, and so a lack of access to such methods can
increase costs to the woman and to the program. Information regarding the appropriateness of a method
for a woman’s reproductive intentions is critical for any market-shaping initiatives; thus, investments in
generating such evidence would be extremely helpful.

Associations between FP Use, Non-Use, and Distal Outcomes
A central goal of family planning is to enable women to space and limit their children according to their
own needs and desires. Family planning provides the means through which a woman’s right to have
children by choice and not by chance can be actualized. In addition, FP has important social, economic,
environmental, and population implications. The associations between FP use and fertility, maternal,
infant, and child health, population dynamics, economic development, poverty reduction, and food
security are well-established after decades of research (Bongaarts et al. 2012; Bongaarts and Sinding
2011). This evidence is used primarily to advocate for political and financial commitment, which has
proved essential in refocusing global and national attention on the adverse outcomes associated with
unintended pregnancy and unwanted fertility. This evidence is also used for development planning by
countries with emerging economies, as the integral role of population health and dynamics in poverty
reduction and a country’s economic and social growth is increasingly grasped by politicians and
economists.
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Going forward, a continued investment in the generation and interpretation of demographic evidence
remains critically important, especially in countries where the fertility transition is not yet complete and
where important fluctuations in these relationships must be monitored. Moreover, in countries that
could potentially benefit from a “demographic dividend” – when the working age population is
increasing faster than the dependent population, leading to rapid economic growth (Cleland 2012) –
country-specific analyses that inform policymakers and politicians of how this dividend can be achieved
would be important advocacy interventions and should be supported. A recent review of the likelihood
of a demographic dividend in Africa cautions against expecting the same scale of dividend as those
witnessed in East and South Asia unless the institutional setting is favorable, the economy is able to
generate employment and provide education and health care for the increasing labor force, and
household savings can lead to productive investments (Cleland 2012). Without these associated factors,
rapidly increasing numbers of unemployed, poorly educated young people can lead to discontent and
strife.
As the number of women in the reproductive age group increases because of population growth, so
does the number of women needing contraceptive services and commodities. Thus for many
developing countries seeking to increase access to FP, an important outcome is that the number of
commodities required will increase dramatically due to the combination of increasing contraceptive
prevalence and increasing population size; for example, between 2008 and 2012, an additional 42
million women were using contraceptives, half of which was due to population growth (Singh and
Darroch 2012).
More recently, research on the associations between FP use, population growth (especially in urban
populations and those living on coastal and desert fringes), the environment, and climate has become
increasingly prominent and will continue to do so (Jiang and Hardee 2011). Although links between
global climate patterns and a woman’s right and means of having children by choice and not by chance
may seem too distant to many, evidence from such analyses will become increasingly important for
policy discussions and investment choices, especially in countries suffering from environmental
degradation and problems meeting the food, water, and sanitation needs of their populations.

Using Research, Monitoring, and Evaluation for Guidance Development
The scientific evidence that informed this review draws from data collected through numerous
methodologies and from a variety of sources. Broadly speaking, these can be categorized into: a)
Research studies using social science methods to collect and analyze quantitative or qualitative data
using designs that seek to maximize the validity and reliability of the findings (including, for example,
the DHS); b) Formal evaluations of the feasibility, acceptability, cost, and effectiveness of service
delivery and system strengthening interventions that seek to increase access to and use of FP; c)
HMISs that routinely monitor systems performance in delivering FP information and services.
Much of the focus in this review has been on research to improve health systems. The past decade has
seen a burgeoning of research strategies, approaches and methods being applied to generate evidence to
influence decisions around health systems strengthening; indeed, global conferences on health systems
research held in 2010 and 2012 attest to the sheer scale of research being undertaken. An unfortunate
consequence has been the plethora of definitions and terms that have been developed and applied to
this research, resulting in confusion and misunderstandings, not least among research donors and
researchers themselves. A review and framing of the key domains (operational, implementation, health
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systems) that comprise research to improve health systems (Remme et al. 2010) provides a useful
starting point from which research donors and researchers can understand and agree upon definitions
and categories of research for framing and organizing future research investments.
Evidence for informing strategic investments to increase access to FP derives primarily from formal
evaluations of intervention feasibility and effectiveness, although those responsible for making such
investment decisions are increasingly seeking evidence of an intervention’s impact on quality of care, on
universal access and equity, and on its sustainability. Evidence of effectiveness is usually considered to be
of highest quality, and so can provide the strongest recommendations for action, if it is derived from a
randomized controlled trial (RCT). As this review found, RCTs are rarely undertaken in FP research for
numerous reasons: they may be too costly; they may not be ethically or practically feasible; or they may
produce evidence that is not programmatically useful. While recognizing the theoretical strength of these
“probability” designs, the role of “plausibility” designs in generating evidence that is of acceptable quality
to decision-makers and can be used to make strong recommendations is gaining acceptance (BoschCapblanch and Team 2011; Victora, Habicht and Bryce 2004). Such designs are often quasi-experimental
and use multiple methods and sources to generate data that provides a plausible, rather than statistically
probable, attribution of effect to the intervention
being evaluated.
Evidence Gaps: Areas for
Research Investment
Recommendations for expanding access to FP that
derive from research-based evidence are frequently
Approaches to Determining Inequities and Identifying
Needs of Underserved and Vulnerable Populations
framed as service delivery ‘guidelines’ or systems
strengthening ‘guidance’, defined in a WHOMethodologies to Prospectively Evaluate Structural
commissioned handbook as “the systematically
Interventions to Reduce Inequities and Vulnerability
developed body of knowledge, integrating research
Interventions to Meet the Needs of Unmarried and
evidence and descriptions of the types of other
Married Adolescents
considerations needed to inform decision making
about appropriate health system arrangements in
Interventions to Improve and Sustain the Quality of
specific settings” (Bosch-Capblanch 2011); The
FP Services
handbook proposes a rigorous and systematic process
Strategies for Scaling up Effective Models of
for reviewing and using research-based evidence for
Integrated Services
health systems guidance and policymaking (BoschCapblanch et al. 2012; Lavis et al. 2012; Lewin et al.
Strategies for Reaching Rural Communities
2012).
What qualifies as high quality “evidence” and what is a
“best” or “proven” implementation practice remains
open to debate, however. Other approaches to
reviewing and synthesizing evidence and formulating
guidance have accepted evidence from non-RTC
designs and more experiential evidence, for example
DFID’s series of “evidence reviews” on Reproductive,
Maternal and Newborn Health, and USAID’s “High
Impact Practices in Family Planning (HIPs)”. Lack of
agreement on the criteria for evidence quality and its
use in the formulation of policy and programmatic
recommendations, especially at the global level, will
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Strategies for Reaching Urban Poor Populations
Techniques for Defining and Shaping Contraceptive
Markets to Improve Availability and Access
Innovative Financing Mechanisms to Expand Access
and Increase Affordability
Strategies for Advocacy and Accountability
Understanding the Dynamics of Contraceptive
Decision-Making and Use
Building Capacity and Improving Methods to
Generate and Use Evidence on FP

inhibit FP2020’s ability to introduce and expand effective interventions for reducing unmet need;
achieving such consensus is an urgent priority.

Research Gaps
This review shows that a substantial body of evidence concerning the determinants, outcomes and
dynamics of contraceptive use and unmet need has been, and continues to be, generated through a
range of research and evaluation activities. Prior investments over several decades in research and
evaluation, including building capacity to produce and use research-based evidence, has yielded an
impressive body of knowledge that has guided the development and expansion of FP information and
services in many developing countries.
The commitments made at the London FP Summit, and the establishment of the FP2020 initiative to
implement these, require that many developing countries will need to rapidly and efficiently increase the
scale and intensity of existing FP delivery systems, while simultaneously expanding the number and
diversity of public and non-public sector markets through which FP can be accessed by those needing
FP services. The evidence base to guide how best to do this is, however, lacking in several key areas, as
described above. The following evidence gaps warrant consideration for immediate investment in
research and in building research capacity.
Approaches to Determining Inequities and Identifying Needs of Underserved and
Vulnerable Populations
Although the social determinants of FP demand and use are well understood, how these function in
specific national and sub-national contexts must to be clearly mapped if countries are to implement
rights-based approaches to reducing unmet need. For many countries, population-level surveys, in
addition to or as a component of a regular DHS, that are designed to more precisely determine inequities
in access to and use of FP are needed urgently to inform programming, policy and, importantly,
budgetary allocations and investments within a country’s FP2020 plan. Using these surveys as a baseline,
they should be repeated regularly to detect and monitor whether reductions in inequities are occurring
and whether underserved and vulnerable populations are being reached.
Such research should proactively engage those often excluded in routine surveys, such as married and
unmarried girls and boys, sex workers, migrants, and indigenous and slum populations. In-depth analyses
should also be conducted to determine the specific needs of vulnerable and underserved populations and
to identify targeted interventions that would increase their access and empower them to hold the health
system accountable. This evidence would also provide countries the opportunity to provide “voice” to its
vulnerable groups so that they can actively engage in FP programming.
Methodologies to Prospectively Evaluate Structural Interventions to Reduce Inequities and
Vulnerability
The importance of structural determinants in limiting access and use of FP is well-understood; much
more evidence is needed, however, of the feasibility and effectiveness of interventions that can reduce
the inequities and vulnerabilities that they cause. Evidence of the effectiveness of interventions that
reduce early marriage, reduce unmarried girls’ exposure to unwanted and coerced sex, and empower
women to meet their reproductive intentions is largely non-existent. Evidence is also needed concerning
“gendered” interventions that enable more positive and balanced interactions by girls and women with
their partners, families, and communities. Prospective, rigorously designed impact evaluations of multi19

faceted structural interventions are needed. Although requiring substantial investments of time and
funding, they would generate evidence that would not only increase FP use but also improve social
relations, gender dynamics, and women’s and girls’ rights more widely.
Interventions to Meet the Needs of Unmarried and Married Adolescents
Adolescent girls and boys, both married and unmarried, form substantial proportions of those with
unmet need; moreover, they are often among the most vulnerable and underserved of populations and
their needs for appropriate sexuality education are often as great as their need for contraceptives.
However, despite the evidence generated through many and varied initiatives over the past two decades,
context-specific research is critical if countries are to better understand the needs, preferences and
circumstances of the many and extremely varied groups of adolescents that exist in all societies. The
diversity of “adolescence” cannot be overemphasized, and so combinations of social science and
operations research are needed to first diagnose the varied needs of different adolescent groups and to
then test and scale-up sustainable strategies that are appropriate for addressing the educational,
informational and service needs of the different adolescents. Moreover, national HMISs urgently need to
be strengthened so as to collect, analyze, and use data disaggregated by age and other critical
determinants of adolescents’ FP needs.
Interventions to Improve and Sustain the Quality of FP Services
FP2020 recognizes and endorses all individuals’ right to the highest quality of care; moreover, existing
evidence indicates that poor-quality counseling and delivery are universal barriers to initiation and
sustained use of FP. More evidence is needed to identify feasible and acceptable interventions that
enable and require providers to respond to their clients’ individual needs. Evidence is also needed of
their effectiveness and sustainability in both attracting new FP users and in reducing discontinuation, as
well as their ability to ensure that the distinct needs of vulnerable and underserved populations are
appropriately met. Investment in context-specific operations and implementation research around quality
improvement interventions would enable health systems to address the many method-and programrelated factors that are the most commonly cited reasons for non-use of contraception among women
with an unmet need. A key research investment would be the strengthening of quality assurance and
monitoring mechanisms to ensure that such improvements are standardized, routinized, and sustained.
Strategies for Scaling up Effective Models of Integrated Services
Integrating FP within other health services is an important strategy for FP2020; integrated services can
be more accessible, acceptable, affordable and less stigmatized, and there may be greater efficiencies in
service delivery. Evidence of the feasibility, acceptability and effectiveness of various models of FP
integration with antenatal, delivery, postpartum and postabortion care, and with HIV services, is wellestablished. Evidence of how to adapt, scale-up, and institutionalize these models within a national
health system is lacking, however, in part because there is little experience of offering integrated services
at scale. Prospective implementation research is needed that systematically documents strategies for
scaling up various proven models through describing the systems-level organizational modifications (e.g.
in commodity supplies, provider training and supervision, M&E, etc.), policy adjustments, budgetary
reallocations, and the costs and cost-savings involved when expanding an integrated model proven
through a small-scale pilot study.
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Strategies for Reaching Rural Communities
Many developing countries are still characterized by largely rural, often remote, populations. Evidence
supports the effectiveness of CHW programs in expanding access to FP among these populations and so
expansion of such programs is likely to feature significantly in many national FP2020 initiatives.
Countries would benefit, however, from investments in operations and implementation research that
would enable them to fine-tune this proven best practice to their national contexts and to rapidly roll-out
coverage to better reach underserved and vulnerable populations. CHWs can also be important strategies
for reaching populations living in urban informal or ‘slum’ settlements. Greater investment in policy
analyses and health systems research would guide countries in incorporating community-level services
into the formal health system, especially countries seeking to adapt national models that have been
proven effective by NGOs or faith-based organizations (FBOs).
Existing evidence also supports investment in expansion of a second proven strategy for reaching rural
communities, that is, mobile outreach services, which can be an essential source of long-acting reversible
and permanent contraception, thereby complementing the delivery of short-acting methods that
characterizes most CHW programs. However, investment in operations and implementation research
would help countries to rapidly adapt this strategy in both public and non-public programs.
Strategies for Reaching Urban Poor Populations
Rapid urbanization is leading to burgeoning populations of urban poor that are often more
disadvantaged and have poorer reproductive and maternal health than the rural poor. Despite
geographical proximity to a wide range of outlets, access to affordable and appropriate services is often
constrained. Evidence-based strategies for reaching the rapidly growing urban poor will be critical for
FP2020, given the scale of growth in these populations and the increasing share the urban poor will
contribute to unmet need. Private sector pharmacies, drug sellers, and commercial retail outlets—either
independently or within a social marketing program—have tremendous potential to complement public
(and private) facilities in urban areas, but evidence of feasibility, affordability, quality of care, and
effectiveness in engaging with the private sector to reach the urban poor are lacking. A “total market”
approach, including a range of research activities to assess and analyze the situation and opportunities,
would be particularly appropriate when planning and developing strategies to reach the full spectrum of
slum dwellers.
Techniques for Defining and Shaping Contraceptive Markets to Improve Availability and
Access
Market shaping will feature prominently in FP2020 and is a process that requires much more evidence of
contraceptive demand and use dynamics and of commodity market dynamics than is currently available –
or than can be generated with existing research methods. Developments in research methods are needed
urgently, by drawing initially from the experiences of organizations and donors undertaking market
shaping in other health fields (e.g. HIV, malaria) and adapting these techniques to contraceptive market
development approaches. Investments in building the capacity of FP researchers to understand and
apply these methods, and of health system planners to understand and use the data generated from
market shaping analyses, are needed immediately if this key element of FP2020 is to be successful.
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Innovative Financing Mechanisms to Expand Access and Increase Affordability
The impressive commitments of financial and other resources for FP2020 can only be successful if the
systems in which they are invested function efficiently and ensure that a full range of affordable
contraceptive options are available to as wide a population as possible. PBF is emerging as a potential
complement to conventional input-based public-sector financing for health systems generally, but little
evidence exists concerning PBF of FP services. Investment in operations and implementation research
to evaluate and compare the cost, effectiveness and equity effects of various PBF models in the public
and non-public sectors with conventional input-based financing models is essential and urgently needed.
As most national health systems will continue to finance FP services through input-based financing,
however, (at least during the lifetime of FP2020), research is also needed to better understand these
financing mechanisms and to identify interventions to improve their functioning and efficiency.
As contraceptive markets continue to diversify, the price of contraceptive commodities, both to
governments and to users, will become an increasingly important factor. Further evidence is needed,
which can be researched with existing methods, about users’ willingness and ability to pay, and about the
role of method pricing in determining access for vulnerable and marginalized populations as well as the
method mix available, especially in public sector programs.
Strategies for Advocacy and Accountability
Two major and interrelated thrusts of FP2020, for which clear conceptualizations are lacking and there is
little research-based evidence of what is effective, are interventions for advocacy (to ensure that
commitments are actually made and invested appropriately) and for accountability (to empower
communities to engage meaningfully in FP2020-supported initiatives and to institutionalize this
engagement). Given the centrality to the objectives of FP2020 of both advocacy and accountability,
investments in developing an evidence base for both types of interventions should be an urgent priority.
Case studies of existing experiences, operations research that develops and tests various interventions,
and rigorous M&E mechanisms to document their implementation and assess their impact would be
helpful in building this evidence base.
Understanding the Dynamics of Contraceptive Decision-Making and Use
To reduce unmet need effectively, a national program first needs to fully understand the reasons why
women, girls, and their partners do or do not use contraception when they are at risk of an unintended
pregnancy, and how these reasons vary among different population groups. Country-specific social
science research is needed to analyze these reasons and their determining factors so as to identify which
delivery strategies, financing mechanisms, demand generation strategies or commodity mix options
would best address the various barriers to use, disaggregated by key population groups. Moreover,
methodological developments are needed to better measure and explain socio-behavioral determinants
of demand and use, including risk perception, ambivalence, and fear, both for the women and their
partners. This research is particularly needed in settings and for populations marked by low literacy rates,
poverty, and low contraceptive prevalence.
Recent evidence reinforces the major contribution to unmet need and unintended pregnancy of
discontinuation and method failure or inconsistent/incorrect use of contraceptives. Context-specific
social science and acceptability research are needed to inform programs of the reasons for method
discontinuation or failure so that interventions can be developed and tested through operations research
to reduce the causative factors. Such evidence can also inform market shaping (to identify appropriate
method mixes for particular populations) and product development (to guide new product designs).
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Building Capacity and Improving Methods to Generate and Use Evidence on FP
The human resources needed to undertake the research that will address these evidence gaps remains
highly concentrated in northern countries and organizations; a substantial and immediate investment in
building southern-based research capacity is critical if evidence generation is to be institutionalized and
sustained in the countries that need the evidence. Moreover, some evidence gaps will need new or
adapted measures and research methods, which will require investment in their development, validation,
and testing in a variety of contexts. Additionally, despite the heavy reliance on national HMISs for data
to evaluate FP services, virtually all HMISs in developing countries generate data of dubious validity;
investment is urgently needed to strengthen HMISs in most developing countries, especially through
computerization, as well as the capacity of program managers to extract and use the data reported.
While increasing emphasis on evidence-informed decision-making by donors and national health systems
is welcomed and strongly endorsed, the capacity of decision-makers, in both developing and developed
countries, to interpret and use research-based evidence is mixed. In particular, there is much confusion
and a lack of agreement about procedures for collating and synthesizing evidence from various sources,
including research, for formulating recommendations for programming. For guidance in “best practices”
to be recommended, there needs to be greater consensus among decision-makers, especially in donor
and policymaking organizations, on what constitutes high-quality evidence and which types of evidence
provide the greatest degree of confidence for making strong recommendations. Uncertainty over the
credibility of evidence not generated through RCTs and the role of experiential evidence are just two of
the factors confusing the role of evidence in programmatic recommendations.

Looking Ahead
Research shows that through high-quality voluntary FP programs, governments can reduce fertility and
generate substantial improvements in health, wealth, human rights, and education. Family planning
programs for the 21st century will require thoughtful design—engaging both public and private sectors—
to meet the growing need for safe and effective FP services. Moreover, the combination of substantial
commitments to FP2020 from national governments and a wide range of development partners presents
a major challenge in coordinating efforts by multiple actors with different expectations and ways of
functioning.
A new generation of women and men will be entering their reproductive years during FP2020; they
represent future global markets, future parents, and future FP users. Efforts to provide timely, accurate,
and culturally appropriate information can contribute to the RH of many. The challenges ahead for FP
programs will be to increase overall access while reducing inequities in individuals’ ability to use a
method of their choice, particularly inequities due to poverty, gender, age, and marital status. This
requires investments in research that not only informs health systems strengthening but also empowers
girls and women to make and act upon their own best decisions about pregnancy and childbearing.
These challenges need to be addressed in the context of constantly increasing population sizes in most
developing countries, necessitating additional investments just to sustain existing levels of need.
We must seize the moment and “capitalize on the growing momentum to establish family planning
programs as accepted, expected, and routine elements of national health care systems worldwide”
(Bongaarts et al. 2012).

23

Glossary of Terms and Definitions
Contraceptive prevalence
The percentage of women who are currently using, or whose sexual partner is currently using, at least
one method of contraception, regardless of the method used. It is usually reported for married or inunion women aged 15 to 49.
(http://www.who.int/reproductivehealth/topics/family_planning/contraceptive_prevalence/en/)
Market development approaches (MDAs) to reproductive health are initiatives that work toward
enhanced financial sustainability, improved access and expanded choice. The term “market
development approach” encompasses a very broad set of approaches to health care delivery, but by
definition involves the commercial sector.
Market shaping
Market shaping (in this context) is defined as supporting the efficient procurement of quality
commodities while ensuring sustainable supply at affordable prices to eligible countries.
(http://www.gavialliance.org/library/gavi-documents/white-papers/market-shaping--strategicconsiderations-for-a-healthy-vaccine-marketplace
Market segmentation
Market segmentation is the process of dividing the total market into smaller subsets (segments) that
have similar characteristics, needs, or behaviors. Market segmentation analysis looks at current patterns
of demand and use for RH commodities and the characteristics of users—socioeconomic,
sociocultural, and behavioral—in order to find better and more efficient ways to meet existing demand
or generate increased demand.
(http://deliver.jsi.com/dhome/topics/policy/csinitiatives/marketsegmentation
Market segmentation strategies are used by businesses to divide their customers into distinct groups
based on different factors, such as income, and to target their products accordingly. In FP, market
segmentation is used to divide the FP market into groups based on choice of method and provider and
to match clients with sources based on need and ability to pay.
http://www.fhi.org/en/RH/Pubs/booksReports/fpfinancing/brief3.htm
Population momentum
The tendency for population growth to continue beyond the time that replacement-level fertility has
been achieved because of the relatively high concentration of people in the childbearing years.
(http://www.prb.org/Educators/Resources/Glossary.aspx)
Social determinants
The social determinants of health are the conditions in which people are born, grow, live, work and age,
including the health system. These circumstances are shaped by the distribution of money, power and
resources at global, national and local levels. The social determinants of health are mostly responsible for
health inequities—the unfair and avoidable differences in health status seen within and between
countries. (http://www.who.int/social_determinants/en/)
Inter-related social and economic factors that influence health. Social determinants of health include, but
are not limited to: socioeconomic status, discrimination, housing, physical environment, food security,
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child development, culture, social support, healthcare services, transportation, working conditions, and
democratic participation.
Structural interventions
Structural interventions refer to public health interventions that promote health by altering the structural
context within which health is produced and reproduced. Structural interventions differ from many
public health interventions in that they locate, often implicitly, the cause of public health problems in
contextual or environmental factors that influence risk behavior, or other determinants of infection or
morbidity, rather than in characteristics of individuals who engage in risk behaviors.
(http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1473169/)
Interventions designed to remove barriers and incorporate facilitators of an individual’s HIV prevention
(health-seeking, disease prevention) behaviors. These barriers or facilitators include physical, social,
cultural, organizational, community, economic, legal, or policy circumstances or actions that directly or
indirectly affect an individual’s ability to avoid (disease, poor health) exposure to HIV.
(http://www.cdc.gov/hiv/topics/evaluation/health_depts/guidance/glossary.htm)
Structural approaches include social, economic, and political interventions that can improve public
health outcomes by increasing the willingness and ability of individuals to practice prevention.
(http://www.aidstarone.com/focus_areas/prevention/pkb/structural_interventions/overview_stru
ctural_approaches_hiv_prevention)
Total fertility rate
The number of children who would be born per woman (or per 1,000 women) if she/they were to
pass through the childbearing years bearing children according to a current schedule of age-specific
fertility rates. The TFR is the most widely used fertility measure in program impact evaluations for two
main reasons: (1) it is unaffected by differences or changes in age-sex composition, and (2) it provides
an easily understandable measure of hypothetical completed fertility.
(http://www.cpc.unc.edu/measure/prh/rh_indicators/specific/fertility/total-fertility-rate)
The average number of live births a woman would have by age 50 if she were subject, throughout her
life, to the age-specific fertility rates observed in a given year. Its calculation assumes that there is no
mortality. (http://www.un.org/esa/sustdev/natlinfo/indicators/methodology_sheets/demographics/
total_fertility_rate.pdf)
Total market approach
Having the public and nonprofit sectors provide subsidized services for needy consumers while
maintaining sustainable commercial provision for consumers who are able to pay is often referred to as a
“total market” or “whole market” approach.
(http://www.rhsupplies.org/fileadmin/user_upload/MDA_Documents/Total_Market_Initiatives_f
or_Reproductive_Health.pdf)
DFID defines a TMA as a process to “assess the characteristics of existing and likely future markets,
and to define the comparative advantage of commercial, social marketing, non-governmental
organization, and public sector actors in terms of competence and value for money in delivering a range
of products or services to different market segments, including the poorest. It can enable closer and
more structured linkages with commercial, public and non-governmental organizational sectors and aid
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the gradual shifting of consumers with sufficient purchasing power out of the public sector.”
(http://shopsproject.org/sites/default/files/resources/5010_file_Total_Market_Approach_honey
manp3.pdf
Unmet need
The percent with an unmet need for family planning is the number of women with unmet need for
family planning expressed as a percentage of women of reproductive age who are married or in a union.
Women with unmet need are those who are fecund and sexually active but are not using any method of
contraception, and report not wanting any more children or wanting to delay the birth of their next child.
(http://www.who.int/reproductivehealth/topics/family_planning/unmet_need_fp/en/index.html)
Youth bulge
A high proportion of 15-to-29 year olds relative to the adult population.
(http://blogs.worldbank.org/developmenttalk/youth-bulge-a-demographic-dividend-or-ademographic-bomb-in-developing-countries)
The youth bulge is a common phenomenon in many developing countries, and in particular, in the least
developed countries. It is often due to a stage of development where a country achieves success in
reducing infant mortality but mothers still have a high fertility rate. The result is that a large share of the
population is comprised of children and young adults, and today’s children are tomorrow’s young adults.
(http://blogs.worldbank.org/developmenttalk/youth-bulge-a-demographic-dividendor-a-demographicbomb-in-developing-countries)
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